DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Telehealth platforms have reshaped who seeks treatment for androgenetic alopecia, pulling the typical first-time patient several years younger than a decade ago. Men in their late twenties and early thirties now drive much of the demand for oral and topical regimens, motivated partly by early intervention messaging. The shift has expanded a market once dominated by older consumers, with subscription pricing lowering the barrier to starting daily therapy.
Telehealth platforms have reshaped who seeks treatment for androgenetic alopecia, pulling the typical first-time patient several years younger than a decade ago. Men in their late twenties and early thirties now drive much of the demand for oral and topical regimens, motivated partly by early intervention messaging. The shift has expanded a market once dominated by older consumers, with subscription pricing lowering the barrier to starting daily therapy.